{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:37Z","timestamp":1793237677467,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330047"],"award-info":[{"award-number":["82330047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170342"],"award-info":[{"award-number":["82170342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2288101"],"award-info":[{"award-number":["T2288101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["X24AI003"],"award-info":[{"award-number":["X24AI003"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["yg2023-01"],"award-info":[{"award-number":["yg2023-01"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20251019"],"award-info":[{"award-number":["GZC20251019"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3603300"],"award-info":[{"award-number":["2023YFC3603300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3603400"],"award-info":[{"award-number":["2023YFC3603400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymthe.2026.03.033","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:59:50Z","timestamp":1775030390000},"page":"4212-4225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PKC activators improve the function of biogenesis-deficient CFTR channels"],"prefix":"10.1016","volume":"34","author":[{"given":"Shi-Wei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Lei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0724-0723","authenticated-orcid":false,"given":"Shi-Qing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.03.033_bib1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.03.033_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/344665a0","article-title":"A frame-shift mutation in the cystic fibrosis gene","volume":"344","author":"White","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.033_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","article-title":"Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis","volume":"63","author":"Cheng","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.033_bib4","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.11.014","article-title":"Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator","volume":"167","author":"Zhang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.033_bib5","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41591-018-0200-x","article-title":"Structure-guided combination therapy to potently improve the function of mutant CFTRs","volume":"24","author":"Veit","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.033_bib6","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.0706974104","article-title":"Processing and function of CFTR-DeltaF508 are species-dependent","volume":"104","author":"Ostedgaard","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.033_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2021.12.009","article-title":"Mechanism of CFTR correction by type I folding correctors","volume":"185","author":"Fiedorczuk","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.033_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cell.2019.12.032","article-title":"A Therapy for Most with Cystic Fibrosis","volume":"180","author":"Bear","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.033_bib9","first-page":"3","article-title":"CFTR modulator therapies - Effect on life expectancy in people with cystic fibrosis","volume":"42","author":"Balfour-Lynn","year":"2022","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.ymthe.2026.03.033_bib10","article-title":"The era of CFTR modulators: improvements made and remaining challenges","volume":"16","author":"Cuevas-Oca\u00f1a","year":"2020","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.ymthe.2026.03.033_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.03.033_bib12","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.033_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2015.09.003","article-title":"A combination therapy for cystic fibrosis","volume":"163","author":"Brodsky","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.033_bib14","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.03.033_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.ade2216","article-title":"Molecular structures reveal synergistic rescue of Delta508 CFTR by Trikafta modulators","volume":"378","author":"Fiedorczuk","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.033_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-2600(24)00411-9","article-title":"Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials","volume":"13","author":"Keating","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ymthe.2026.03.033_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105262","article-title":"Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment","volume":"22","author":"Capurro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.03.033_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139983","article-title":"Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination","volume":"5","author":"Veit","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.03.033_bib19","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1021\/acs.jmedchem.1c01897","article-title":"Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives","volume":"65","author":"Brusa","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2026.03.033_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-physiol-021014-071838","article-title":"Alternative paradigms for ion channelopathies: disorders of ion channel membrane trafficking and posttranslational modification","volume":"77","author":"Curran","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ymthe.2026.03.033_bib21","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1113\/jphysiol.2010.190652","article-title":"Neurological channelopathies: new insights into disease mechanisms and ion channel function","volume":"588","author":"Kullmann","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.ymthe.2026.03.033_bib22","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1038\/ncomms6535","article-title":"Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome","volume":"5","author":"Anderson","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.033_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nurt.2007.01.010","article-title":"Episodic ataxia type 1: a neuronal potassium channelopathy","volume":"4","author":"Rajakulendran","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2026.03.033_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12264-023-01118-6","article-title":"Ion Channel Dysregulation Following Intracerebral Hemorrhage","volume":"40","author":"Zhang","year":"2024","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ymthe.2026.03.033_bib25","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1038\/s41467-018-06514-5","article-title":"Identification of small-molecule ion channel modulators in C. elegans channelopathy models","volume":"9","author":"Jiang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.033_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/rr69","article-title":"Glycosylation and the cystic fibrosis transmembrane conductance regulator","volume":"2","author":"Scanlin","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.ymthe.2026.03.033_bib27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cell.2011.07.021","article-title":"Rescue of DeltaF508-CFTR trafficking via a GRASP-dependent unconventional secretion pathway","volume":"146","author":"Gee","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.033_bib28","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/sj.bjp.0703520","article-title":"Effect of genistein on native epithelial tissue from normal individuals and CF patients and on ion channels expressed in Xenopus oocytes","volume":"130","author":"Mall","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.03.033_bib29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.033_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031437","article-title":"Assays of CFTR Function In Vitro, Ex Vivo and In Vivo","volume":"23","author":"Ramalho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.03.033_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1183\/09031936.02.00229202","article-title":"Mechanisms and markers of airway inflammation in cystic fibrosis","volume":"19","author":"De Rose","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ymthe.2026.03.033_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1073\/pnas.0303411101","article-title":"Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator","volume":"101","author":"Chappe","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.033_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","article-title":"An atlas of substrate specificities for the human serine\/threonine kinome","volume":"613","author":"Johnson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.033_bib34","doi-asserted-by":"crossref","first-page":"W243","DOI":"10.1093\/nar\/gkad383","article-title":"GPS 6.0: an updated server for prediction of kinase-specific phosphorylation sites in proteins","volume":"51","author":"Chen","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.03.033_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206146120","article-title":"DNA topoisomerase 2-associated proteins PATL1 and PATL2 regulate the biogenesis of hERG K(+) channels","volume":"120","author":"Yao","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.033_bib45","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.286","article-title":"Polysome Preparation, RNA Isolation and Analysis","volume":"2","author":"Zhang","year":"2012","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.ymthe.2026.03.033_bib36","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1101\/gad.1348805","article-title":"Lost in translation: the influence of ribosomes on bacterial mRNA decay","volume":"19","author":"Deana","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.03.033_bib37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1073\/pnas.84.2.498","article-title":"Induced mRNA stability in Bacillus subtilis","volume":"84","author":"Bechhofer","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.033_bib38","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1002\/j.1460-2075.1995.tb07328.x","article-title":"The stability of Escherichia coli lacZ mRNA depends upon the simultaneity of its synthesis and translation","volume":"14","author":"Iost","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2026.03.033_bib39","doi-asserted-by":"crossref","first-page":"C417","DOI":"10.1152\/ajpcell.2000.278.2.C417","article-title":"PKA holoenzyme is functionally coupled to CFTR by AKAPs","volume":"278","author":"Huang","year":"2000","journal-title":"Am. J. Physiol. Cel Physiol."},{"key":"10.1016\/j.ymthe.2026.03.033_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22281","article-title":"RNA binding proteins PTBP1 and HNRNPL regulate CFTR mRNA decay","volume":"9","author":"Siddiqui","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ymthe.2026.03.033_bib41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41467-017-00444-4","article-title":"Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell","volume":"8","author":"Bagdany","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.033_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fphar.2012.00137","article-title":"Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis","volume":"3","author":"Chanoux","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.03.033_bib43","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.03.033_bib44","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1016\/j.cell.2024.04.046","article-title":"Structure-based discovery of CFTR potentiators and inhibitors","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:26:19Z","timestamp":1793237179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1525001626002182"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.033","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PKC activators improve the function of biogenesis-deficient CFTR channels","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}